EFPIA Newsletter 28 March 2019

How should we value the innovative cancer medicines that are transforming patient outcomes?     A blog by Nathalie Moll, EFPIA Director General   While our scientists, doctors and patients push the boundaries of medical science, it is crucial that we have evidence-based conversations about how to bring evidence-based medicines to those who need them. A recent WHO technical report on the pricing of cancer medicines has sparked a lively debate on oncology spending and access to life-changing therapies. While we have fundamental concerns about the approach taken in the report, and the conclusions the authors reached, it offers opportunities for some fresh thinking on the future of cancer care.  Read more →

Blog     18 March 2019 #ForTheChance to be confident The story of Ayesha, living with cancer Read more →

Videos

	EFPIA Manifesto: Building a healthier future for Europe We have a vision for a healthier world. We can see a brighter tomorrow for all patients. #WeWontRest until we get there. Read the full EFPIA Manifesto at: https://efpia.eu/manifesto/		For The Chance To... Millions of people wouldn't be here today if it wasn't for life-changing science. And many more wouldn't be living the lives they do.

Events     27 JUN 2019   EFPIA 2019 Annual Conference Radisson Blu Royal Hotel, Brussels, Belgium Making connections can advance patient care and support the European economy at a time of significant change and challenge... Learn more →       23 JUN 2019   WIN 2019 Symposium Paris, France A symposium dedicated to Innovation and global deployment of Precision Oncology Learn more →

	21 MAY 2019			EU Pharmaceutical Law Forum The Hotel Brussels, Brussels, Belgium Europe’s leading pharmaceutical law networking and knowledge hub on competition law, patent litigation, regulatory frameworks,... Learn more →

	18 JUN 2019			FT Digital Health Summit 2019 Berlin Collaboration is key to effectively harnessing digital disruption to ease the strain and deliver more adaptable and... Learn more →

What we are reading 20 years of sampling and testing programme for medicines authorised for the EU 28 March 2019  (European Medicines Agency) Read more → HARMONY Anonymization Concept Reconciles Data Quality, Safety, and Privacy 28 February 2019  (The HARMONY Alliance) Read more →

About the EFPIA newsletter The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55 Communications@efpia.eu ▶ in

EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe